Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

Syndax Pharmaceuticals (SNDX) Net Margin: 2015-2020

Historic Net Margin for Syndax Pharmaceuticals (SNDX) over the last 5 years, with Dec 2020 value amounting to -5,226.32%.

  • Syndax Pharmaceuticals' Net Margin fell 148816.00% to -5,226.32% in Q4 2020 from the same period last year, while for Dec 2020 it was -4,708.17%, marking a year-over-year decrease of 91523.00%. This contributed to the annual value of -1,346.11% for FY2024, which is 10199995.00% down from last year.
  • Latest data reveals that Syndax Pharmaceuticals reported Net Margin of -5,226.32% as of Q4 2020, which was up 0.23% from -5,238.26% recorded in Q3 2020.
  • In the past 5 years, Syndax Pharmaceuticals' Net Margin ranged from a high of -1,594.89% in Q4 2017 and a low of -5,238.26% during Q3 2020.
  • For the 3-year period, Syndax Pharmaceuticals' Net Margin averaged around -4,500.82%, with its median value being -4,544.99% (2018).
  • In the last 5 years, Syndax Pharmaceuticals' Net Margin spiked by 197,003bps in 2017 and then plummeted by 349,274bps in 2018.
  • Syndax Pharmaceuticals' Net Margin (Quarterly) stood at -3,564.92% in 2016, then surged by 197,003bps to -1,594.89% in 2017, then tumbled by 349,274bps to -5,087.63% in 2018, then surged by 134,947bps to -3,738.16% in 2019, then tumbled by 148,816bps to -5,226.32% in 2020.
  • Its Net Margin stands at -5,226.32% for Q4 2020, versus -5,238.26% for Q3 2020 and -4,382.59% for Q2 2020.